Recent Event Highlights: Emory Hosts HIV Vaccine Meeting - The Emory Wheel, Testing African couples for HIV is cost-effective prevention strategy - EurekAlert (press release), Novel discoveries offer new ways to design HIV vaccine - Sify, AIDS VACCINE 2010, The only conference dedicated to HIV vaccine research opens ... - GLTNewsNow, Biojector(R)2000 Utilized in a Human Clinical Trial of DNA-MVA HIV Vaccine - MarketWatch (press release), Inovio readies candidate HIV vaccine - WHYY (blog), and 163 more...
Created by dipity on Sep 24, 2009
Last updated: 10/28/10 at 12:06 PM
Emory Hosts HIV Vaccine MeetingThe Emory WheelBy Jordan Friedman Emory served as the local host for the Global HIV Vaccine Enterprise's 10th annual conference, ...New vaccine could cut TB infections by 90%Cosmosall 3 news articles »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGRALwc7O7l14rd_A_ixQoba_jF6A&url=http://www.emorywheel.com/detail.php?n%3D28749
ReutersTesting African couples for HIV is cost-effective prevention strategyEurekAlert (press release)As researchers and policymakers work toward an effective HIV vaccine in a constrained global economy, cost-effective prevention strategies such as Couples ...Plan on AIDS vaccine backedAfrica Science News ServiceWorld failing to meet HIV/AIDS care target: UNBangkok PostA Star-Studded, Global Phenomenon Set to Wrap the Planet in a Giant Embrace of ...PR Web (press release)all 6 news articles »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEiK1js-pSsPtZ-sR1DwnG0l8tB8A&url=http://www.eurekalert.org/pub_releases/2010-09/eu-tac093010.php
MedIndiaNovel discoveries offer new ways to design HIV vaccineSify"Nobody yet can make a vaccine that elicits these broadly neutralizing antibodies, but here are patients who can do it, so let's understand how," Nature ...HIV vaccine scientists vow to speed up searchCBC.caViewpoints / Atlanta's AIDS conference: A regional and global perspectiveAtlanta Journal ConstitutionHIV vaccine researchers ponder new strategies, drop in fundingFierceVaccinesTheBody.com -PR-USA.net (press release) -Scientistall 59 news articles »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHl-Mp2gSc53SzM73Hsqk56c1r-2Q&url=http://sify.com/news/novel-discoveries-offer-new-ways-to-design-hiv-vaccine-news-international-kj4o4fidjac.html
Biomed Middle EastAIDS VACCINE 2010, The only conference dedicated to HIV vaccine research opens ...GLTNewsNowBy Staff Report ( Atlanta , 28 September 2010) — Advances in the search for a safe and effective HIV vaccine will be the focus of nearly 1100 researchers, ...An HIV vaccine is within sight but the field is threatened by funding cutsThe GuardianStrategy to fight HIV shapes upNature.comNIH scientists freeze virus fragment in shape recognized by immune systemEurekAlert (press release)Trading Markets (press release) -VaccineNewsDailyall 60 news articles »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE4k-ipunSKFb_cBYZTxou_0X1L1A&url=http://gltnewsnow.com/2010/09/28/aids-vaccine-2010-the-only-conference-dedicated-to-hiv-vaccine-research-opens-in-atlanta/
Biojector(R)2000 Utilized in a Human Clinical Trial of DNA-MVA HIV VaccineMarketWatch (press release)Once the vaccine combination has been assessed as safe and acceptable in twelve HIV-uninfected participants in the US, the study will begin at four MHRP ...and more »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFh-qbxgdpPiXAsbubgRs881Z3llw&url=http://www.marketwatch.com/story/biojectorr2000-utilized-in-a-human-clinical-trial-of-dna-mva-hiv-vaccine-2010-09-28?reflink%3DMW_news_stmp
WHYY (blog)Inovio readies candidate HIV vaccineWHYY (blog)Scientists have been looking for a vaccine against the AIDS virus for more than 25 years. A Montgomery County company is one of the latest biotech firms to ...and more »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFoUADNs4X9zKA23wKLHLg_I8Azsg&url=http://whyy.org/cms/news/health-science/2010/09/24/inovio-readies-candidate-hiv-vaccine/46670
Proactive Investors USA & CanadaInovio Pharmaceuticals testing new type of HIV vaccinePhiladelphia Business Journal (blog)The multicenter study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network. “Enrollment for this trial was completed ahead ...Inovio Completes Enrollment of HIV Clinical Trial for DNA Vaccine Delivered ...PipelineReview.com (press release)Inovio Completes Enrollment of Clinical Trial for HIV DNA VaccineProactive Investors USA & CanadaInovio Pharmaceuticals to Present at Investor Conferences In New York and San ...MarketWatch (press release)all 36 news articles »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNET7IqDNNNNWSsJzB5uwF4bV60Caw&url=http://philadelphia.bizjournals.com/philadelphia/blogs/health_care/2010/09/inovio_pharmaceuticals_testing_new_type_of_hiv_vaccine.html
Excerpt
...the writers themselves accept, the availability of treatment for HIV patients simply cannot keep up with demand. An HIV vaccine is our best hope for stopping the spread of the virus. And an effective HIV vaccine is dependent on more, better and safer human...
Source Info
Change.org
http://humanrights.change.org/blog/view/next_steps_in_hiv_vaccine_research
As an international leader in HIV/AIDS vaccine research, Emory University has more than 50 scientists focused on developing an effective vaccine for this challenging disease. Research at the Emory University Center for AIDS Research, the Emory Vaccine Center and its Hope Clinic, Yerkes National Primate Research Center, and Emory University School of Medicine ranges from basic research in the laboratory to preclinical studies in animals to human clinical trials to a biotech start-up. Background The Emory University Center for AIDS Research (CFAR) is pleased to serve as local Atlanta host for AIDS Vaccine 2010, sponsored by the Global HIV Vaccine Enterprise. (See related video: www.youtube.com AIDS 2010 is scheduled for Sept. 28 to Oct. 1, 2010. This annual international conference brings together scientists, community advocates, funders and policy makers from around the world to hear cutting edge scientific results, exchange new ideas, educate future leaders and engage a diverse community of scientists in the quest for an HIV vaccine. AIDS Vaccine 2010 will feature daily plenary presentations by leading researchers, clinicians and community advocates, and oral and poster presentations of hundreds of research papers addressing every aspect of HIV vaccine development and testing. The conference is expected to attract more than 1000 researchers, clinicians and community advocates from around the world to Atlanta. Eric Hunter, PhD, Georgia Research Alliance eminent scholar and ...
Mymetics' Novel HIV Vaccine to Begin New NIH-Funded Study at University of ...MarketWatch (press release)Christopher J. Miller to Lead Proof-of-Concept Study on Innovative HIV Vaccine Aimed at Preventing Mucosal Transmission and Infection in Macaque Monkeys; ...and more »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH2-tLfKWjsJtXhxYbgg311oU7fQw&url=http://www.marketwatch.com/story/mymetics-novel-hiv-vaccine-to-begin-new-nih-funded-study-at-university-of-california-davis-2010-09-13?reflink%3DMW_news_stmp
TopNews United Kingdom (blog)UTSW seeks volunteers for HIV vaccine trialDallas VoiceThe study, funded by the HIV Vaccine Trials Network, “may help us better understand why some people develop AIDS and others don't,” Jain said. ...UT Southwestern researchers testing new HIV vaccineAustin American-Statesman (blog)UT SOUTHWESTERN RECRUITING PARTICIPANTS FOR HIV VACCINE STUDYOut In Americaall 44 news articles »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHO2XyRFWcnYCcd1ozc9RACdOe1aQ&url=http://www.dallasvoice.com/ut-southwestern-volunteers-hiv-vaccine-trial-1043432.html
Excerpt
The Council of the Global HIV Vaccine Enterprise on Tuesday released a newstrategy for HIV vaccine research, which marked "the culmination of an 18-month effort that included the input of 400 scientists worldwide," VOA News reports (DeCapua, 9/7).
The
Source Info
News-Medical.net
http://www.news-medical.net/news/20100909/Team-of-scientists-issues-HIV-vaccine-strategy.aspx
More Human Trials Needed for HIV Vaccine HuntMedPage TodayHIV vaccine researchers are calling for more and better human trials as part of the search for ...New AIDS Vaccine Strategic Plan UnveiledVoice of AmericaWhere is HIV vaccine research heading?AidsmapBody Releases New Plan To Get an HIV VaccineAfrica Science News ServicePR Newswire (press release) -FierceVaccines -Medical News Today (press release)all 35 news articles »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGy18RNlvIhi-MNKNnu1I3b9JFoRA&url=http://www.medpagetoday.com/HIVAIDS/HIVAIDS/22065
The Center for AIDS Research at Emory University (CFAR) will serve as Local Host of AIDS Vaccine 2010, the largest and most important global scientific conference focused on AIDS vaccine research. Taking place in Atlanta this year, conference's global host is Global HIV Vaccine Enterprise. Background AIDS 2010 is scheduled for Sept. 28 to Oct. 1, 2010. This annual international conference brings together scientists, community advocates, funders and policy makers from around the world to hear cutting edge scientific results, exchange new ideas, educate future leaders and engage a diverse community of scientists in the quest for an HIV vaccine. AIDS Vaccine 2010 will feature daily plenary presentations by leading researchers, clinicians and community advocates, and oral and poster presentations of hundreds of research papers addressing every aspect of HIV vaccine development and testing. The conference is expected to attract more than 1000 researchers, clinicians and community advocates from around the world to Atlanta. Eric Hunter, PhD, Georgia Research Alliance eminent scholar and co-director, Center for AIDS Research at Emory University, will chair AIDS Vaccine 2010 with support from the following co-chairs: James Curran, MD, MPH, dean, Rollins School of Public Health and co-director, Center for AIDS Research, Emory University; Carlos del Rio, MD, Hubert professor and chair of the Hubert Department of Global Health, Rollins School of Public Health and co-director, Center ...
For more information, visit us at www.SFisReady.org "This is my way of giving back to all of those people I've lost." ~ Ray You can't miss Daddy Ray walking down the street. He stands out. He became SF Leather Daddy in August, 2008, one of several leather titles he has held. Part of the title requires volunteer work, and volunteering for the vaccine study was just one part of that for him. But volunteering, in general, made being SF Leather Daddy particularly special. Ray also owns a hair salon in Benicia, CA. Many of the people ray knew when he came out are gone now because of HIV He participated in a vaccine study because if they had had a vaccine, they might still be alive today. For more information, visit us at www.SFisReady.org
For more information, visit us at www.SFisReady.org "HIV is still alive, still well, still infecting people here in the US, here in San Francisco and around the world." ~ Jamie Jamie has finished two Ironman triathlons. He has always loved training his body to run, cycle, and swim, and lately, he's focusing inward to train his mind for a more mindful existence. He's originally from northern Maine, and the river that forms the US border runs through his parents' backyard. He has lived in San Francisco for almost eight years, moving here from the Peninsula where he lived and worked for over ten years. Jamie volunteered for a vaccine study with his partner, Eduardo, because he felt like it was an easy and convenient way to make a real impact on the epidemic. For more information, visit us at www.SFisReady.org
For more information, visit us at www.SFisReady.org "Volunteering in the study is basically helping the community to find a vaccine." ~ Eduardo Eduardo has lived in San Francisco for more than a decade, and he was born and raised in Mexico. He is a very busy man. He has a full-time job as a project manager in a product safety testing company. In his free time, he runs his own business, EcoRiffic, designing and wholesaling reusable bags made from 100% recycled plastic bottles. He also volunteers with the San Francisco Bicycle Coalition, the Friends of the Urban Forest, and he reads, eats dinner with friends, and loves to travel. He also speaks fluent Japanese. Eduardo made time to volunteer because he believes a vaccine is particularly important for the Latino community, where HIV is a big issue, but very heavily stigmatized. For more information, visit us at http
For more information visit us at www.SFisReady.org "Volunteering in the study is basically helping the community to find a vaccine." ~ Eddie Eduardo has lived in San Francisco for more than a decade, and he was born and raised in Mexico. He is a very busy man. He has a full-time job as a project manager in a product safety testing company. In his free time, he runs his own business, EcoRiffic, designing and wholesaling reusable bags made from 100% recycled plastic bottles. He also volunteers with the San Francisco Bicycle Coalition, the Friends of the Urban Forest, and he reads, eats dinner with friends, and loves to travel. He also speaks fluent Japanese. Eduardo made time to volunteer because he believes a vaccine is particularly important for the Latino community, where HIV is a big issue, but very heavily stigmatized. For more information visit us at http
Learn more at www.SFisReady.org "It has been a part of my growth to participate in this trial." ~ Deirdre Deirdre is originally from Vermont, but she's lived in San Francisco for about five years. She loves her aquarium, favoring fresh water tropical fish, especially really tiny ones. She's kind of a homebody, she loves to be cozy at home reading, or writing poetry and short stories. She has even had some of her work published in a local magazine. She always speaks her mind, and believes in telling people exactly what she's thinking. She is proud of joining a vaccine study, often telling her friends she is part of the project. She feels it is particularly important for trans women to participate, since researchers need to know how the vaccine might work for them. Learn more at http
HIV has been able to outmaneuver every vaccine that's been tried on the virus since it was first discovered in 1981. But no vaccine has yet to directly employ what is arguably the most powerful weapon the human immune system, the dendritic cells that orchestrate the body's response to infection. Now that's about to change. Researchers at Rockefeller University, where dendritic cells were discovered in 1973, are building on decades worth of research to launch a novel vaccine trial in hopes of mustering an immune response strong enough to defeat the deadly virus. It's the first clinical trial of a dendritic cell based vaccine against infection, and researchers hope it will mark a turning point in the battle against AIDS.
A team of scientists from the National Institutes of Health in Bethesda, Maryland, outside of Washington has discovered two powerful human antibodies that stop almost all known strains of HIV in the laboratory. The discovery was made possible by using antibodies taken from the blood of someone infected with HIV who has managed to control the disease. While the news is exciting, researchers caution the findings are just another development in the search for a cure. But as VOA's Melinda Smith reports, the scientific evidence could open the gates to an eventual vaccine.
Recruiters go online to find volunteers for HIV vaccine studyEDGE BostonThe Seattle-based HIV Vaccine Trials Network, an international collaboration of scientists and educators searching for an effective and safe vaccine against ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.edgeboston.com%2Findex.php%3Fch%3Dnews%26sc%3D%26sc2%3Dnews%26sc3%3D%26id%3D104301&usg=AFQjCNHAImMQhiOSwH9gjpXqlzpqXw92Fg
New York Times (blog)Antibodies that inhibit HIV infection foundThe HinduPTI AP A technician works on blood samples taken to test an AIDS vaccine. File photo In a finding that could help develop a potential HIV vaccine, ...Scientists Find Clues to How the Body Fights Off HIVBusinessWeekVanderbilt HIV clinical trial shows promiseThe TennesseanNewsHour Examines Research Of HIV Positive Patients Who Can Suppress The VirusMedical News Today (press release)Voice of America -VaccineNewsDaily -Post Chronicleall 178 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fbeta.thehindu.com%2Fhealth%2Farticle389764.ece&usg=AFQjCNG6HhDR0MPv3xzMOIzX_JJt-f-nsw
What Will it Take to Find an HIV Vaccine? People Like You Joining People Like Us. For more information visit www.sfisready.org or call (415) 554-9068 Globally, 33 million people are living with HIV and 2.7 million new infections happen every year. Right here in San Francisco, there will be more than 1000 new infections this year, that's about 10-15 new infections every week. We need an HIV vaccine to stop this epidemic. It will take thousands of healthy, HIV-negative volunteers, 18-45 years old, to find one. The vaccines we are testing cannot cause HIV infection. Volunteers in the study receive HIV and STD testing, and treatment or referral for treatment. Volunteers also receive risk reduction counseling at every visit, and are reimbursed for their time (about $50/visit). An effective vaccine will train the bodys immune system to fight off disease before a person is ever exposed to the real thing. For an HIV vaccine, that might prevent an HIV negative person from getting infected, help someone who gets infected stay healthy longer, or prevent the disease from spreading. For more information visit www.sfisready.org or call (415) 554-9068
Atlanta Business Chronicle (blog)GeoVax to raise $40M for clinical trialAtlanta Business Chronicle (blog)A metro Atlanta biotech company plans to raise $40 million to help pay for an HIV vaccine clinical trial. Smyrna-based Geovax Inc. ( OTC Big Board: GOVX.ob) ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.bizjournals.com%2Fatlanta%2Fblog%2Fatlantech%2F2010%2F04%2Fgeovax_to_raise_40m_for_clinical_trial.html&usg=AFQjCNF85O0zbv8fPKI2GjdlDut6RPZKrQ
The HinduIn Peru, 'Elite' AIDS Patients Boost Vaccine Research EffortsNewsHourRAY SUAREZ: Walker hopes clues will emerge from studying elite controllers that will ultimately lead to an HIV vaccine. DR. ...Will an AIDS Pill a Day Keep the Virus Away?BusinessWeekBloomberg Examines Potential Benefits, Drawbacks to PrEPTheBody.comEast Africa: The Military as 'Agents for Change'AllAfrica.comall 97 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.pbs.org%2Fnewshour%2Fbb%2Fhealth%2Fjan-june10%2Fperu_04-01.html&usg=AFQjCNEOth8_SVzR2ajW9mwzn53Mq7daRw
Smyrna-based Biotech Company Ready to Test "Therapeutic" HIV VaccineWABEATLANTA, GA (WABE) - A metro Atlanta biotech company has received FDA approval to test what it calls a "therapeutic" HIV vaccine. WABE's Jim Burress reports ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.publicbroadcasting.net%2Fwabe%2Fnews.newsmain%2Farticle%2F1%2F0%2F1631231%2FAtlanta%2FSmyrna-based.Biotech.Company.Ready.to.Test.'Therapeutic'.HIV.Vaccine&usg=AFQjCNGUzuWNgbRb603J2NazCF1ukq3r5w
Global BCCanada cuts off funding to international AIDS vaccine projectVancouver SunIn 2007, when Canada announced its own Canadian HIV Vaccine Initiative, Canada committed that the CHVI "would not compromise Canada's international support ...Canada makes more cuts to HIV vaccine researchXtra.caCanada drops international AIDS projectUPI.comCanada Ceases Funding to International AIDS Vaccine ProjectTopNews United Statesall 48 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.vancouversun.com%2Fhealth%2FCanada%2Bcuts%2Bfunding%2Binternational%2BAIDS%2Bvaccine%2Bproject%2F2749387%2Fstory.html&usg=AFQjCNElnqSoJIdFArzifX7NdPwtO_SaNw
Biological/Research Material for HIV Vaccine ResearchTechCombo (blog)The resulting recombinant virus made from pJH4, MVA/SIV239gagpol, expresses the SIV 239gagpol gene and thus can be used to conduct vaccine studies in animal ...Methods to Increase Stability of Recombinant Vaccinia-Vectored Vaccines and ...TechCombo (blog)all 2 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Ftechcombo.com%2F2010%2F03%2F31%2Fbiologicalresearch-material-for-hiv-vaccine-research-123%2F&usg=AFQjCNEn7OP_Pzf6mO9Hsf53pkDY2SW44Q
Gates study on HIV vaccine facility 'fatally flawed': expertWinnipeg Free PressOTTAWA -- A new report from a Canadian vaccine expert pours water on the Harper government's argument a non-profit HIV vaccine manufacturing facility is no ...New Path to Therapeutic HIV Vaccine Discovered by Studying Immunologic Profile ...PR-CANADA.net (press release)all 24 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.winnipegfreepress.com%2Flocal%2Fgates-study-on-hiv-vaccine-facility-fatally-flawed-expert-88532227.html&usg=AFQjCNEJg-nBGyslfeJMw4VDsGrPrdZd1A
The HinduAn HIV Vaccine Made From Bananas?InventorspotThen the BanLec was tested by the research team and found to be an effective anti-HIV lectin, similar in potency to T-20 and maraviroc, anti-HIV drugs ...Lectins from Bananas Help to Avoid HIV InfectionTopNews United StatesProtein in bananas could help block spread of HIV, University of Michigan ...AnnArbor.comDrug from bananas to prevent HIV infectionMorungExpressSoftpedia -The Hindu -TopNewsall 141 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Finventorspot.com%2Farticles%2Fhiv_vaccine_made_bananas_38918&usg=AFQjCNGXBk4andCt2n2QUEVgajkZI-Euvg
TopNews United StatesFinances sank HIV vaccine facility bidCBC.ca(Chris Young/Canadian Press) The decision not to build a planned multimillion-dollar HIV vaccine manufacturing facility in Canada was based on finances, ...Health Department Under Scrutiny after Scrapping HIV Vaccine Facility PlanTopNews United StatesHealth boss grilled on city vaccine planWinnipeg Free PressFeds drop plans to build vaccine facilityMontreal Gazette580 CFRA Radio -Winnipeg Free Pressall 44 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.cbc.ca%2Fcanada%2Fmanitoba%2Fstory%2F2010%2F03%2F16%2Fhiv-vaccine-isotopes-aglukkaq-butler-jones.html&usg=AFQjCNGK0RU_CHCYVBGmzXJXxg6_PNvwXQ
The Faster TimesTop 2009 Global Pandemic Happenings: Part 1The Faster TimesVolunteers were followed up for 3 years in the largest HIV vaccine trial to date. While the numbers of people who became HIV positive during the trial were ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fthefastertimes.com%2Fglobalpandemics%2F2009%2F12%2F31%2Ftop-2009-global-pandemic-happenings-part-1%2F&usg=AFQjCNEzu93Mv9hBTFbrNMwwi6kqwO57Jw
RadioFreeEurope/RadioLibertyScience And Technology That Changed The World In 2009RadioFreeEurope/RadioLibertyPerhaps the biggest health breakthrough of the year, however, was an HIV trial vaccine that resulted in a 31 percent lowered risk of infection. ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.rferl.org%2Fcontent%2FScience_And_Technology_That_Changed_The_World_In_2009%2F1918578.html&usg=AFQjCNFHq8RHO-tiVwopWNje-0ccPJ4rcA
Hope Clinic seeks gay men for HIV vaccine trialProject Q AtlantaIt's an opportunity to get involved “in a real visceral way” with HIV vaccine research, beyond attending a fundraiser or donating to a worthwhile charity, ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.projectqatlanta.com%2Fnews_articles%2Fview%2Fhope_clinic_seeks_gay_men_for_hiv_vaccine_trial%3Fgid%3D4635&usg=AFQjCNGg2rdC8oMa8y7771xA0UkpKcSHxg
Zambian WatchdogIn search for an HIV vaccine, all is not doom and gloomWashington Post16 editorial "The incurable epidemic," which suggested that scientists are not making progress in the search for an HIV vaccine or microbicide. ...NAC says it's aware of Mazabuka HIV infectionsZambian WatchdogZambia: AIDS trial volunteers contract virusAfricaNewsall 5 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2009%2F12%2F23%2FAR2009122302912.html&usg=AFQjCNHWz5MEfMx3kP8bR6_YTQ9X1K9SHA
Daily MonitorAfrican govts asked to fund HIV vaccineNew VisionLEADERS from Africa have been asked to fund research for an AIDS Vaccine. The call was made by participants of the 5th African AIDS ...Women shy away from HIV vaccine trialsDaily MonitorUganda to host Africa centre to battle AidsDaily NationAfrican AIDS Vaccine Conference Addresses Future Trials In Africa, Lower ...Medical News Today (press release)Uganda Media Centre -AllAfrica.com -BusinessWeekall 46 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.newvision.co.ug%2FD%2F8%2F13%2F704674&usg=AFQjCNFwNMrcy4qCVJo11Wcjfp1fRTiuUg
Scientists move closer to HIV vaccineUPI.comThe researchers previously showed a rabies-based vaccine expressing HIV and simian immunodeficiency virus antigens was protective against a chimeric HIV-SIV ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.upi.com%2FScience_News%2F2009%2F12%2F16%2FScientists-move-closer-to-HIV-vaccine%2FUPI-32221260996221%2F&usg=AFQjCNHO1XWrkUMNUY-th_Z13rpDDRnLtg
Excerpt
...experiment will be useful in developing a vaccine that works. "This is the first time that any vaccine trial in humans of an HIV vaccine has shown any positive effect, very modest thought it was," Anthony Fauci, director of the National Institute of Allergy...
Source Info
The Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2009/12/15/AR2009121504873.html?nav=rss_opinions
Health NewstrackHIV/AIDS: The incurable epidemicWashington Post"This is the first time that any vaccine trial in humans of an HIV vaccine has shown any positive effect, very modest thought it was," Anthony Fauci, ...HIV prevention gel fails to reduce risk: scientistsXinhuaMicrobicide Offers No Protection from HIV in Large TrialMedPage TodayDisappointment as microbicide fails to protect against HIVAidsmapLos Angeles Times (blog) -Daily Monitor -Belfast Telegraphall 268 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2009%2F12%2F15%2FAR2009121504873.html&usg=AFQjCNGfDwFKloOVNbt1x8T96h8DYD26Xg
CTV.caCity will hold another H1N1 clinicThe Salem News... (including that caused by medications or by HIV). Vaccine will be administered on a first-come, first-served basis to members of the priority groups. ...Town offering H1N1 clinicsNorthJersey.comGet free swine flu shots, GWAHS urges communityCowra Community NewsFirst death from H1N1 virus reported in Cattaraugus CountyEvening Observerall 3,183 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.salemnews.com%2Fpunews%2Flocal_story_347213057.html%3Fkeyword%3Dtopstory&usg=AFQjCNEwJ_yGIudxsNquz1tabJ4ms-6gEA
New study shows HIV/AIDS vaccine can reduce infection rate by 40%Xinhua10 (Xinhua) -- A new study to be unveiled here next week shows that an HIV vaccine with a 60 percent efficacy can reduce the infection rate of HIV/AIDS by ...Health briefs • December 11, 2009Dallas Voiceall 108 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fnews.xinhuanet.com%2Fenglish%2F2009-12%2F11%2Fcontent_12627731.htm&usg=AFQjCNEswrlMtEzJnNo0EJal5n4E7DW23A
The VoiceVaccine no replacement for HIV testingPrivate MD... highest priority," Saladin Osmanov, coordinator of the HIV-vaccine initiative overseen by the World Health Organization and UNAIDS, told the Journal. ...2009 World AIDS DayThe CurrentScientists find HIV stowaway that helps its transmissionThe Hinduall 53 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.privatemdlabs.com%2Fnews%2FHIV_monitoring%2FTreatment%2FTesting%2FPost_Diagnos%2FVaccine-no-replacement-for-HIV-testing%2419502395.php&usg=AFQjCNFInzt5uo_s6UjdV1B__OcO-8DYlw
About 600.000 people in Thailand are thought to be living with Aids, but the country has won praise for its attempts to tackle the spread of the HIV virus. Education and increasing access to anti-retroviral drugs are the mainstay of the Thai campaign, while initial optimism over a supposedly "breakthrough" HIV vaccine has waned. Al Jazeera's Aela Callan reports from Bangkok.
The world has been waiting for the scientific community to announce a break through in the search for an hiv vaccine in vain. However, scientists have not given up and recently raised hopes of attaining a safe and highly effective vaccine following the conclusion of the largest ever HIV vaccine clinical trial in Thailand. But as another world aids day approaches, an effective vaccine is still far from being discovered, and the best way not to get the virus is by protecting yourself.
What would you do if you discovered a vaccine for HIV ? How would it feel ? What would you say ? Would the stigma and discrimination continue ? 2 days, 8 people, One Challenge, Amoryvida - The Ultimate Promise for Life !
Excerpt
...new institutional arrangements must be made between manufacturing countries and testing countries, where HIV incidence is highest. “Instituting these changes will be every bit as important for HIV vaccine development as getting the science right.”...
Source Info
RedOrbit
http://www.redorbit.com/news/health/1780988/publicprivate_partnerships_a_must_in_creating_hiv_vaccine/index.html?source=r_health
Excerpt
...years of investment and perseverance are paying off. One cannot predict the duration of the journey to licensable HIV vaccines, but one does begin to feel that the wind has filled the sails. In 2005, the members of the UN and the G8 resolved to provide universal...
Source Info
Huffington Post
http://www.huffingtonpost.com/dr-seth-berkley/aids-vaccine-investment-i_b_338652.html
Update Sources
